Antiproliferative Effect of <i>N</i>-Heterocyclo-Coumarin Derivatives against Multidrug-Resistant Cells
作者:Koji Wada、Masuo Goto、Kuo-Hsiung Lee、Hiroshi Yamashita
DOI:10.1248/cpb.c22-00585
日期:2023.1.1
Chemotherapy refers principally to the use of small molecules to treat cancer, and natural product derivatives have been main sources of clinically using anticancer drugs. While the coumarin skeleton does not inhibit cell growth, its derivatives are often active, and numerous coumarins have been examined for antiproliferative activity against human cancer cell lines. In this study, 16 novel coumarin derivatives (1, 1a–5a, 1b, 2b, 6b, 7b, 8–13) with attached N-heterocycles, including aminopyrrolidine, aminopiperidine, aminoazepane, and indoline, were prepared and ultimately esterified or amidated with alcohols or amines, respectively. All synthesized N-heterocycles containing coumarin derivatives with alcohols, amines, and carboxylic acids were assessed for antiproliferative activity against several human cancer cell lines, containing triple-negative breast cancer (TNBC) as well as a P-glycoprotein (P-gp) overexpressing multidrug-resistant (MDR) KB subline KB-VIN. Five coumarin derivatives (3a–5a, 12, 13) showed no effect (IC50 >40 µM) against all tested cell lines. In contrast, derivative 1a showed broad-spectrum activity against four cell lines, while 1b and 10 were nearly twice as selective for KB-VIN cells as the parent KB. The coumarin derivatives 1a, 1b, and 10 were optimal for antiproliferative activity in this study and could provide a new avenue for overcoming MDR tumors. Derivatives 1a, 1b, and 10 showed MDR cell-selective antiproliferative activity, indicating that N-heterocycle-coumarins exert previously unexplored bioactivity with selective action on MDR cancer cells.
化疗主要指使用小分子治疗癌症,
天然产物衍
生物一直是临床上使用抗癌药物的主要来源。虽然
香豆素骨架不能抑制细胞生长,但其衍
生物通常具有活性,许多
香豆素已被证实对人类癌
细胞系具有抗增殖活性。在这项研究中,制备了16种新型
香豆素衍
生物(1、1a-5a、1b、2b、6b、7b、8-13),这些衍
生物带有N杂环,包括
氨基
吡咯烷、
氨基
哌啶、
氨基氮杂
环庚烷和
吲哚啉,并最终分别与醇或胺酯化或酰胺化。对所有合成的含
香豆素衍
生物的N杂环与醇、胺和
羧酸的混合物进行了评估,以确定其对几种人类癌
细胞系的抗增殖活性,包括三阴性乳腺癌(T
NBC)以及P-糖蛋白(P-gp)过度表达的多药耐药(MDR)KB子系KB-VIN。五种
香豆素衍
生物(3a-5a、12、13)对所有测试的
细胞系均无影响(IC50>40μM)。相比之下,衍
生物1a对四种
细胞系具有广谱活性,而1b和10对KB-VIN细胞的选择性几乎是母体KB的两倍。在这